WallStreetZenWallStreetZen

NASDAQ: AEZS
Aeterna Zentaris Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their AEZS stock forecasts and price targets.

Forecast return on equity

Is AEZS forecast to generate an efficient return?

Forecast return on assets

Is AEZS forecast to generate an efficient return on assets?

AEZS revenue forecast

What is AEZS's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$4.3M-4%

AEZS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AEZS$8.52N/AN/A
ONVO$1.03N/AN/A
BNOX$0.90$8.00+786.92%Buy
OGEN$2.33N/AN/A
CHRO$1.75N/AN/A

Aeterna Zentaris Stock Forecast FAQ

What is AEZS's revenue growth forecast for 2024-2024?

(NASDAQ: AEZS) Aeterna Zentaris's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Aeterna Zentaris's revenue in 2024 is $4,498,000.

In 2024, AEZS is forecast to generate $5,241,918 in revenue, with the lowest revenue forecast at $5,241,918 and the highest revenue forecast at $5,241,918.

If you're new to stock investing, here's how to buy Aeterna Zentaris stock.

What is AEZS's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: AEZS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.99%.

What is AEZS's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: AEZS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.